Tuesday, February 17, 2026 | 05:31 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Page 51 - Latest Updates on Q4 Results

Ramco Cements Q4 results: Net profit falls over 20% to Rs 121 crore

Standalone net profit after tax fell over 20% year-on-year to Rs 121 crore ($14.5 million) during January-March, missing analysts' expectations of Rs 127 crore

Ramco Cements Q4 results: Net profit falls over 20% to Rs 121 crore
Updated On : 22 May 2024 | 7:43 PM IST

Power Grid Corporation Q4 results: PAT dips marginally to Rs 4,166 crore

State-owned Power Grid Corporation on Wednesday reported a nearly four per cent dip in its consolidated net profit to Rs 4,166.33 crore in the March 2024 quarter, mainly due to a marginal decline in income. The company reported a consolidated net profit of Rs 4,322.87 crore in the quarter ended on March 31, 2023, a BSE filing showed. Total income declined to Rs 12,305.39 crore in the quarter as compared to Rs 12,557.44 crore in the same period a year ago. For fiscal 2023-24, the consolidated net profit rose to Rs 15,573.16 crore from Rs 15,419.74 crore a year ago. Total income in the fiscal rose to Rs 46,913.12 crore as against Rs 46,605.64 crore in the year-ago period. The board also recommended a final dividend of Rs 2.75 per share (i.e. 27.5 per cent on the paid-up equity share capital) for the financial year 2023-24 subject to the approval of the shareholders at the ensuing annual general meeting of the company. The final dividend will be paid within 30 days from the date of

Power Grid Corporation Q4 results: PAT dips marginally to Rs 4,166 crore
Updated On : 22 May 2024 | 7:41 PM IST

Shriram General Insurance Q4 results: PAT at Rs 121 cr, AUM at Rs 12,064 cr

Shriram General Insurance Company Ltd has reported a net profit for the January-March 2024 quarter at Rs 121 crore, the company said on Wednesday. Shriram General Insurance Company is jointly owned by the diversified conglomerate Shriram Group and South Africa-based Sanlam Ltd. In a statement, the company said it earned a net profit of Rs 121 crore for the quarter ending March 31, 2024 while net profits for the year ending March 31, 2024, stood at Rs 455 crore. The Gross Written Premium during the quarter under review was at Rs 876 crore up by 30 per cent over the same period of last financial year. Commenting on the financial performance, Shriram General Insurance Company Ltd MD and CEO Anil Aggarwal said, "The year gone by has been a milestone for our business as we recorded the highest ever growth since we began our operations in 2008. Our Gross Written Premium rose to 34 per cent exceeding the industry growth of 12.8 per cent." "We expect the FY25 Gross Written Premium Growth

Shriram General Insurance Q4 results: PAT at Rs 121 cr, AUM at Rs 12,064 cr
Updated On : 22 May 2024 | 7:22 PM IST

Torrent Power Q4 results: PAT falls 4.2% to Rs 430 cr on higher fuel prices

Its revenue from operations rose 8.1% to Rs 6,529 crore, however, total expenses, led by fuel cost, rose nearly 10% to Rs 6,008 crore

Torrent Power Q4 results: PAT falls 4.2% to Rs 430 cr on higher fuel prices
Updated On : 22 May 2024 | 7:07 PM IST

Strides Pharma Q4 Results: Posts net profit of Rs 10.44 cr, revenue up 5.6%

In the same quarter of the previous fiscal, Strides reported a loss of Rs 13.79 crore. Ebitda grew 4.61 per cent to Rs 204 crore

Strides Pharma Q4 Results: Posts net profit of Rs 10.44 cr, revenue up 5.6%
Updated On : 22 May 2024 | 5:34 PM IST

Nykaa Q4 results: Net profit rises 187% to Rs 6.9 crore, revenue up 28%

Nykaa Q4FY24 results: FSN E-Commerce Ventures' revenue from operations grew by 28.1% to Rs 1,667.98 crore year-on-year

Nykaa Q4 results: Net profit rises 187% to Rs 6.9 crore, revenue up 28%
Updated On : 22 May 2024 | 5:07 PM IST

Sundaram Finance Holdings Q4 results: Net profit rises 173% to Rs 269.32 cr

Sundaram Finance Holdings Ltd, a part of the TSF Group, has registered a 173 per cent rise in its consolidated net profits for the March 2024 quarter, at Rs 269.32 crore. The city-based company had recorded a consolidated net profit of Rs 98.62 crore during the corresponding quarter last year. For the year ending March 31, 2024, the consolidated net profits grew by 125 per cent to Rs 533 crore, from Rs 237 crore a year ago, Sundaram Finance Holdings said in a statement here on Wednesday. The Board of Directors has recommended a final dividend of Rs 2.05 per share (41 per cent) for FY23-24. This together with the interim dividends aggregated to Rs 7.70 per share (154 per cent) for FY23-24. Sundaram Finance Holdings primarily operates as a holding company owning a portfolio of automotive businesses including foundries, wheels, brakes, turbochargers, and axles. The dividend from portfolio companies forms a substantial part of the financial results. Dividend received from portfolio ..

Sundaram Finance Holdings Q4 results: Net profit rises 173% to Rs 269.32 cr
Updated On : 22 May 2024 | 5:06 PM IST

TeamLease Q4 results: Net profit rises 14% on general staffing strength

The company said consolidated net profit came in at 274.8 million rupees ($3.30 million) for the three months ended March 31

TeamLease Q4 results: Net profit rises 14% on general staffing strength
Updated On : 22 May 2024 | 5:00 PM IST

Sun Pharma Q4 results: Net profit rises 34% to Rs 2,655 cr, revenue up 10%

Sun Pharma Q4FY24 results: The board of the company recommended a final dividend of Rs 5 per equity share of Re. 1 for the financial year 2023-24

Sun Pharma Q4 results: Net profit rises 34% to Rs 2,655 cr, revenue up 10%
Updated On : 22 May 2024 | 4:31 PM IST

Max Healthcare Institute Q4 results: PAT declines by 2.81% to Rs 311 crore

Max Healthcare Institute Ltd on Wednesday reported a 2.81 per cent decline in profit after tax at Rs 311 crore in the fourth quarter ended March 31, 2024. The company had posted a Profit After Tax (PAT) of Rs 320 crore in the same quarter of the previous fiscal, Max Healthcare Institute said in a statement. "The minor drop in PAT is mainly due to lower effective tax rate last year and net loss at new units," the company said. Network gross revenue in the fourth quarter was at Rs 1,890 crore as against Rs 1,637 crore in the year-ago period, it added. The company's board has recommended a final dividend of Rs 1.5 per equity share of face value of Rs 10 for the financial year 2023-24, subject to approval of the shareholders at the upcoming annual general meeting. For the fiscal ended March 31, 2024, PAT was at Rs 1,278 crore as against Rs 1,084 crore in the previous year, the company said. In FY 24, network gross revenue was at Rs 7,215 crore as against Rs 6,236 crore in FY23. Max

Max Healthcare Institute Q4 results: PAT declines by 2.81% to Rs 311 crore
Updated On : 22 May 2024 | 4:22 PM IST

Stock Market Highlights, May 22: Sensex up 268pts, Nifty near 22600; Awfis Space IPO subscribed 1.5x

Stock Market Highlights on Wednesday, May 22, 2024: M-cap of all BSE listed companies settled at Rs 416 trillion or $5 trillion today

Stock Market Highlights, May 22: Sensex up 268pts, Nifty near 22600; Awfis Space IPO subscribed 1.5x
Updated On : 22 May 2024 | 3:50 PM IST

Strides Pharma Q4 results: Net profit declines 24% to Rs 10.44 crore

Strides Pharma Science Ltd on Wednesday reported a consolidated net profit of Rs 10.44 crore in the fourth quarter ended March 2024. The company, which posted a consolidated net loss of Rs 13.79 crore in the same quarter a year ago, announced a top management rejig with Executive Chairperson & Managing Director Arun Kumar designated as Executive Chairperson while Executive Director Finance & Group CFO Badree Komandur has been elevated as MD and Group CEO. Consolidated total income in the quarter under review stood at Rs 1,070.49 crore as against Rs 1,013.49 crore in the same period a year ago, Strides Pharma Science said in a regulatory filing. Total expenses in the fourth quarter were higher at Rs 984.21 crore as compared to Rs 972.26 crore. The board has recommended a final dividend of Rs 2.50 per equity share of Rs 10 each for the financial year ended March 31, 2024, the filing said. For the year ended March 31, 2024, the consolidated net loss was at Rs 94.31 crore as ...

Strides Pharma Q4 results: Net profit declines 24% to Rs 10.44 crore
Updated On : 22 May 2024 | 3:43 PM IST

DB Corp Q4 results: Net profit rises nearly three-fold to Rs 122.52 cr

Media house DB Corp Ltd on Wednesday reported a nearly three-fold jump in consolidated net profit at Rs 122.52 crore for the fourth quarter ended March 31, helped by a broad-based growth across verticals. The company had posted a consolidated net profit of Rs 41.02 crore in the January-March quarter a year ago, DB Corp said in a regulatory filing. Its revenue from operations was up 16.23 per cent to Rs 617.13 crore during the quarter under review. It was at Rs 530.95 crore in the corresponding period of the previous fiscal. The company said its total expenses in the March quarter was at Rs 480.23 crore, down 2.2 per cent. Its revenue from "printing, publishing and allied business" was up 15.42 per cent to Rs 576.28 crore in the March quarter of financial year 2023-24. While revenue from the radio business was at Rs 41.15 crore, up 29.28 per cent. "On a quarterly basis, Q4 FY24 saw broad-based growth for the 11th quarter in a row with 24.6 per cent growth in advertisement revenue

DB Corp Q4 results: Net profit rises nearly three-fold to Rs 122.52 cr
Updated On : 22 May 2024 | 3:04 PM IST

Ircon International shares slide 5% on sluggish Q4 show; profits dip by 4%

The engineering and construction firm saw a decline of 3.8 per cent in its consolidated net profit, totaling Rs 246.8 crore for the March quarter, compared to Rs 256.49 crore from the same period last

Ircon International shares slide 5% on sluggish Q4 show; profits dip by 4%
Updated On : 22 May 2024 | 12:44 PM IST

Paytm Q4 FY24 results: Loss widens to Rs 550 crore, warns of job cuts

Paytm Q4 FY 24 results: Shares of Paytm were trading at Rs 349 at 9:35 am on the BSE following the release of the company's quarter earnings report

Paytm Q4 FY24 results: Loss widens to Rs 550 crore, warns of job cuts
Updated On : 22 May 2024 | 11:07 AM IST

Q4 Results Today: Sun Pharma, Grasim, Nykaa Among 32 Firms to Post Earnings

Company Results Q4 FY24: Jubilant, Ramco Cements, NIIT Learning also anticipated to release fourth quarter earnings on May 22

Q4 Results Today: Sun Pharma, Grasim, Nykaa Among 32 Firms to Post Earnings
Updated On : 22 May 2024 | 11:06 AM IST

Zomato, Paytm: What should investors do with new-age stocks? Analysts weigh

Shares of Zomato have soared 57 per cent so far in 2024, but those of Paytm have tumbled 46 per cent

Zomato, Paytm: What should investors do with new-age stocks? Analysts weigh
Updated On : 22 May 2024 | 10:02 AM IST

Trading guide for May 22: BSE m-cap at $5 trn, Awfis Space IPO, FII selling

Pre-market update for Indian stock markets, May 22, 2024: From global markets to FII flows to IPO alert, here is a complete guide on what all investors need to know before the Opening Bell

Trading guide for May 22: BSE m-cap at $5 trn, Awfis Space IPO, FII selling
Updated On : 22 May 2024 | 8:15 AM IST

GSFCL Q4 results: PAT declines 89% to Rs 24.43 cr, total income falls 16%

Gujarat State Fertilisers and Chemicals (GSFCL) on Tuesday posted a sharp 89 per cent drop in consolidated net profit to Rs 24.43 crore for the fourth quarter of 2023-24 on poor sales. Its net profit stood at Rs 224.91 crore in the same quarter in the preceding fiscal. The total income fell 16.34 per cent to Rs 2,017.46 crore in the January-March quarter of 2023-24 from Rs 2,411.56 crore a year earlier, according to a regulatory filing. The company's expenses remained lower at Rs 1,993 crore in the period under review against Rs 2,105.74 crore a year ago. The company said FY24 was a challenging year due to external headwinds in fertilisers and industrial products segments. "FY23-24 was a challenging year for the company due to external headwinds in both fertilisers and industrial products segments," GSFCL said. However, with a high net-worth proportion in the overall balance sheet size and long-term debt-free position, the company has a strong financial position to fund its capex

GSFCL Q4 results: PAT declines 89% to Rs 24.43 cr, total income falls 16%
Updated On : 21 May 2024 | 9:05 PM IST

Metropolis Healthcare revenue up 17%, targets industry-leading growth

In Q4, the business-to-consumers (B2C) revenues grew by approximately 20 per cent Y-o-Y, and revenues from the Mumbai market also saw 20 per cent growth

Metropolis Healthcare revenue up 17%, targets industry-leading growth
Updated On : 21 May 2024 | 8:24 PM IST